Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for FRESENIUS KABI · Healthcare/pharmaceutical company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 15, 2026

Official filing document

 Bills named in this filing 3
 Lobbying activity 2
Health Issues

Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)

Copyright/Patent/Trademark

Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem